通过工程 hucMSC 衍生 EVs 提供针对性的 mGluR5 激活剂,以增强巨细胞功能和减轻谷氨酸诱导的毒性
Khushi1, Alok Kumar1, Krishna Jadhav2
1Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India.
ACS applied bio materials
|August 19, 2025
概括
来自干细胞的转基因细胞外囊泡 (EVs) 增强了神经炎症疾病的巨细胞的药物输送. 这些工程 EVs 改善细胞功能和生存,显示治疗大脑疾病的前景.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 药物输送系统 药物输送系统
背景情况:
- 细胞外囊泡 (EVs) 由于其生物特性,显示出治疗神经炎症疾病的潜力.
- 目前对EV向的局限性降低了治疗疗效,特别是对于巨细胞.
- 加强EV向对于神经退行性疾病中有效的药物输送至关重要.
研究的目的:
- 为了基因修改人类带介质干细胞 (hucMSC) 衍生的EVs,以加强对表达nAchR的巨细胞的向.
- 评估表面修饰EV的稳定性,特性和细胞吸收.
- 在神经炎症模型中评估药物载荷改造EVs的治疗潜力.
主要方法:
- 使用特定等离子体 (pcDNA3.1-GNSTM-RGV-Lamp2b-HA) 进行hucMSCs和EV隔离的遗传修饰.
- 通过 Ζ - 潜力分析,大小,膜蛋白表达和形态学来表征修饰的 EVs.
- 在实验室中评估巨细胞对EV的吸收,并在培养试验中评估药物载荷的EV疗效.
主要成果:
- 表面修改后的电动汽车表现出稳定性,并保留了基本特征.
- 修改后的EV显示显著增强了巨细胞的吸收.
- 装有药物的改造EV促进了巨细胞的增殖,迁移,减少了细胞死亡,并减轻了氧化应激诱导的细胞循环停止.
结论:
- 基因工程hucMSC衍生的EV为神经炎症疾病提供了更好的准和治疗效益.
- 这种基于EV的药物输送系统显示出治疗神经退行性疾病的潜力.
- 优化的EV修改策略可以克服向药物输送的局限性.
相关概念视频
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...


